The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1 - Concepedia

Concepedia

Publication | Closed Access

The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1

574

Citations

18

References

2017

Year

Andrew A. Wylie, Joseph Schoepfer, Wolfgang Jahnke, Sandra W. Cowan‐Jacob, Alice Loo, Pascal Furet, Andreas L. Marzinzik, Xavier Pellé, Jerry Donovan, Wenjing Zhu,

Molecular PharmacologyDrug TargetMedicineImmunologyAllosteric Inhibitor Abl001Drug Discovery

References

	Year	Citations

Page 1